PROVIDER PROFILE · NPI 1932165255
Patricia ByersMD
PRESCRIBING · PART D · 2024
Total Rx claims
595
Beneficiaries
—
Total drug cost
$8.2M
Distinct drugs
11
Brand share
85.7%
Top prescribed drugs
Teduglutide166 claims
Lipase/Protease/Amylase155 claims
Famotidine/Pf75 claims
Loperamide Hcl58 claims
Famotidine56 claims
QUALITY · MIPS · 2024
Final MIPS score
87.9
Quality
78.8
Cost
71.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.54%
Group
CROSS-REFERENCE